Results 1 - 10 of 232
[PROJECT] CHAGASEPINET - Comparative epidemiology of genetic lineages of Trypanosoma cruzi
ID: 223034
Start date: 2009-01-01, End date: 2012-12-31
The focus of this multidisciplinary proposal is to elucidate the epidemiology of the genetic lineages of T. cruzi, for improved understanding and prevention of Chagas disease. The project will unite skills in genotyping, genomics, genetics and pathogenesis in Europe with cons...
Programme: FP7-HEALTH
Record Number: 88960
Last updated on: 2017-05-25
[PROJECT] EUROCANPLATFORM - A European Platform for Translational Cancer Research
ID: 260791
Start date: 2011-01-01, End date: 2016-12-31
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer r...
Programme: FP7-HEALTH
Record Number: 97701
Last updated on: 2017-05-29
[REPORT SUMMARY] Final Report Summary - EUROCANPLATFORM (A European Platform for Translational Cancer Research)
The EurocanPlatform brought together 28 European cancer Institutions and organisations to work in partnership to structure translational research. The centres shared infrastructures, expertise and collaborated on projects to innovate in cancer research. The overarching aim of...
Programme: FP7-HEALTH
Record Number: 201649
Last updated on: 2017-07-25
[PROJECT] RATHER - Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes
ID: 258967
Start date: 2011-01-01, End date: 2018-06-30
Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signaling components. While there are several ongoing large-scale genome re-sequen...
Programme: FP7-HEALTH
Record Number: 97660
Last updated on: 2017-07-16
[PROJECT] ASFRISK - Evaluating and controlling the risk of African swine fever in the EU
ID: 211691
Start date: 2008-04-01, End date: 2011-09-30
African swine fever (ASF) in EU member states is currently confined to Italy (Sardinia), it was recently introduced to Caucasian regions and it is highly prevalent in sub-Saharan African countries. In both the EC and Africa changes in the epidemiology of the disease have rece...
Programme: FP7-KBBE
Record Number: 88394
Last updated on: 2017-05-29
[PROJECT] IDEAL - Integrated research on DEvelopmental determinants of Aging and Longevity
ID: 259679
Start date: 2011-02-01, End date: 2016-01-31
IDEAL will obtain insight into the role of early life conditions affecting late-life health, disease and aging, and the role of epigenetic regulation therein. IDEAL will identify the determinants and targets of this epigenetic regulation utilizing a resource of unique human c...
Programme: FP7-HEALTH
Record Number: 98424
Last updated on: 2017-07-12
[PROJECT] METOXIA - Metastatic tumours facilitated by hypoxic tumour micro-environments
ID: 222741
Start date: 2009-02-01, End date: 2014-07-31
Recent research suggests that the hypoxic micro-environment of tumours is one of the major drivers of metastatic spread of cancer. Furthermore, hypoxic tumour micro-environments may result in treatment resistance of cancer cells, therefore causing a double effect of reducing ...
Programme: FP7-HEALTH
Record Number: 91061
Last updated on: 2017-07-12
[PROJECT] PANCARESURFUP - PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies
ID: 257505
Start date: 2011-02-01, End date: 2017-01-31
Over the last 40 years, treatment for childhood and adolescent cancer has improved greatly; 5- year survival after childhood cancer is now 80% in developed countries. Approximately 1 individual in 750 of young adults is now a childhood cancer survivor. Epidemiologic data on t...
Programme: FP7-HEALTH
Record Number: 97692
Last updated on: 2017-05-29
[PROJECT] IMPACTT - Immunoglobulin IgY pseudomonas A clinical trial for cystic fibrosis treatment
ID: 261095
Start date: 2011-01-01, End date: 2016-12-31
Cystic Fibrosis (CF) is a chronically debilitating and life threatening medical condition. Respiratory insufficiency and complications of chronic lung infection lead to long term reduction in quality of life and health and even to premature death. Chronic bacterial infections...
Programme: FP7-HEALTH
Record Number: 98326
Last updated on: 2017-05-29
[REPORT SUMMARY] Periodic Report Summary - IMPACTT (Immunoglobulin IgY pseudomonas - a clinical trial for cystic fibrosis treatment)
Project context and objectives:
The objective of the IMPACTT project is to provide an oral immunotherapy based intervention therapy for prophylaxis and treatment of P. aeruginosa infections in patients with Cystic fibrosis (CF) and to make this treatment available to clinic...
Programme: FP7-HEALTH
Record Number: 54864
Last updated on: 2014-07-04
List retrieved on: 2017-08-02
